Search research articles
Contact Us
Filters
Showing results (111-120 of 531) with videos related to
Page
of 54
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 24, 2003
Daptomycin dose-effect relationship against resistant gram-positive organisms
Raymond Cha, Richard G Grucz, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
April 24, 2003
Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release
Elizabeth A Coyle, Raymond Cha, Michael J Rybak
The Journal of Antimicrobial Chemotherapy
|
July 4, 2002
Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium
Renee-Claude Mercier, Carmine Stumpo, Michael J Rybak
The Mount Sinai Journal of Medicine, New York
|
February 1, 1986
Concurrent and noncontiguous squamous and transitional cell carcinomas of a bladder
S S Tabibzadeh, B J Rybak, R Falcone
Antimicrobial Agents and Chemotherapy
|
May 6, 2009
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations
Steven N Leonard, Céline Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
July 18, 2002
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model
George P Allen, Raymond Cha, Michael J Rybak
Pharmacotherapy
|
December 26, 2003
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model
Raymond Cha, Ronda L Akins, Michael J Rybak
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
April 11, 2012
Macrolides and staphylococcal biofilms
Jorge Parra-Ruiz, Céline Vidaillac, Michael J Rybak
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Cefixime
N J Leggett, C Caravaggio, M J Rybak
The Journal of Infectious Diseases
|
April 28, 2009
Accessory gene regulator dysfunction: an advantage for Staphylococcus aureus in health-care settings?
George Sakoulas, Pamela A Moise, Michael J Rybak
Page
of 54
Search research articles
Search
Showing results (111-120 of 531) with videos related to
Sort By:
Page
of 54
Antimicrobial Agents and Chemotherapy
|
April 24, 2003
Daptomycin dose-effect relationship against resistant gram-positive organisms
Raymond Cha, Richard G Grucz, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
April 24, 2003
Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release
Elizabeth A Coyle, Raymond Cha, Michael J Rybak
The Journal of Antimicrobial Chemotherapy
|
July 4, 2002
Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium
Renee-Claude Mercier, Carmine Stumpo, Michael J Rybak
The Mount Sinai Journal of Medicine, New York
|
February 1, 1986
Concurrent and noncontiguous squamous and transitional cell carcinomas of a bladder
S S Tabibzadeh, B J Rybak, R Falcone
Antimicrobial Agents and Chemotherapy
|
May 6, 2009
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations
Steven N Leonard, Céline Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
July 18, 2002
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model
George P Allen, Raymond Cha, Michael J Rybak
Pharmacotherapy
|
December 26, 2003
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model
Raymond Cha, Ronda L Akins, Michael J Rybak
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
April 11, 2012
Macrolides and staphylococcal biofilms
Jorge Parra-Ruiz, Céline Vidaillac, Michael J Rybak
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Cefixime
N J Leggett, C Caravaggio, M J Rybak
The Journal of Infectious Diseases
|
April 28, 2009
Accessory gene regulator dysfunction: an advantage for Staphylococcus aureus in health-care settings?
George Sakoulas, Pamela A Moise, Michael J Rybak
Page
of 54